Related Experiment Videos
[Bronchial carcinoma in subjects under 40]
F Ardissone1, M Rapellino, R Obert
1Università degli Studi di Torino.
Minerva Medica
|December 1, 1989
Summary
Younger patients with bronchogenic carcinoma (lung cancer) show varied survival rates. Advanced disease staging significantly impacts survival more than surgical resection extent.
Area of Science:
- Oncology
- Pulmonology
- Medical Research
Background:
- Bronchogenic carcinoma (lung cancer) is typically diagnosed in older individuals.
- Understanding lung cancer in younger populations is crucial for tailored treatment strategies.
Purpose of the Study:
- To analyze the clinical characteristics and survival outcomes of bronchogenic carcinoma in patients under 40 years old.
- To identify prognostic factors influencing survival in this specific demographic.
Main Methods:
- Retrospective analysis of 30 patients under 40 with histologically confirmed bronchogenic carcinoma.
- Data collection included patient demographics, tumor cell type, disease stage, treatment received (resection vs. non-operation), and survival duration.
Main Results:
- The most common cell types were squamous cell carcinoma (10 patients) and small cell carcinoma (9 patients).
- The majority of patients presented with advanced disease (Stage III: 17, Stage IV: 7).
- Mean survival was significantly longer for surgically treated patients (23.3 months) compared to non-operated patients (4.2 months).
Conclusions:
- Disease stage is a primary determinant of survival in young patients with bronchogenic carcinoma.
- While surgery offers improved survival, early detection and staging are critical for better outcomes in this age group.